# Single-cell transcriptomic analysis of endometriosis provides insights into fibroblast fates and immune cell heterogeneity

**Authors:** Junyan Ma, Liqi Zhang, Hong Zhan, Yun Mo, Zuanjie Ren, Anwen Shao, Jun Lin

PMC · DOI: 10.1186/s13578-021-00637-x · 2021-07-07

## TL;DR

This study uses single-cell analysis to explore endometriosis, revealing fibroblast roles and immune cell changes that may explain the disease's development.

## Contribution

The study provides a single-cell transcriptome atlas of endometriosis, identifying fibroblast subpopulations and immune cell heterogeneity linked to the disease.

## Key findings

- Fibroblast subpopulations and a developmental trajectory were identified in endometriosis.
- T cells in endometriosis were less activated, while monocytes/macrophages increased in lesions.
- Cell-cell interactions showed an imbalanced immune environment promoting endometriosis.

## Abstract

Endometriosis is an oestrogen-dependent disease with an unclear aetiology and pathogenesis affecting 6–10% of the global female population, predominantly those of reproductive age. Herein, we profile the transcriptomes of approximately 55,000 single cells from three groups including ectopic endometrium, eutopic endometrium from women with endometriosis, and eutopic endometrium from healthy women to create a single-cell transcriptome atlas of endometriosis.

We have identified 9 cell types and performed single-cell analysis of fibroblasts, and determined a potential developmental trajectory associated with endometriosis. We also identified fibroblast subpopulations related to endometriosis development and found that StAR played an important role in this process. Moreover, T cells in endometriosis were less activated or inflammatory with decreased effector CD8 + T cells, while the composition ratio of natural killer cells decreased and the percentage of monocytes/macrophages increased in endometriosis cysts. In addition, the effectiveness of immune cells in endometriosis lesions, eutopic endometrium from women with endometriosis, and eutopic endometrium from healthy women was distinct. Cell–cell interaction analyses highlighted the imbalanced immune environment in endometriosis lesions and immune cells in endometriosis could promote the development of the disease.

Our study provided a systematic characterisation of endometriosis and insights into the aetiology and pathology of endometriosis.

The online version contains supplementary material available at 10.1186/s13578-021-00637-x.

## Linked entities

- **Genes:** STAR (steroidogenic acute regulatory protein) [NCBI Gene 6770]
- **Diseases:** endometriosis (MONDO:0005133)

## Full-text entities

- **Genes:** MMRN1 (multimerin 1) [NCBI Gene 22915] {aka ECM, EMILIN4, GPIa*, MMRN}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, CD163 (CD163 molecule) [NCBI Gene 9332] {aka M130, MM130, SCARI1}, TPSAB1 (tryptase alpha/beta 1) [NCBI Gene 7177] {aka TPS1, TPS2, TPSB1, TPSB2, Tryptase-2}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}, MS4A4A (membrane spanning 4-domains A4A) [NCBI Gene 51338] {aka 4SPAN1, CD20-L1, CD20L1, HDCME31P, MS4A4, MS4A7}, KRT18 (keratin 18) [NCBI Gene 3875] {aka CK-18, CYK18, K18}, FOXP3 (forkhead box P3) [NCBI Gene 50943] {aka AIID, DIETER, IPEX, JM2, PIDX, XPID}, RHO (rhodopsin) [NCBI Gene 6010] {aka CSNBAD1, OPN2, RP4}, CXCL12 (C-X-C motif chemokine ligand 12) [NCBI Gene 6387] {aka IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1}, CXCL5 (C-X-C motif chemokine ligand 5) [NCBI Gene 6374] {aka ENA-78, SCYB5}, CXCL2 (C-X-C motif chemokine ligand 2) [NCBI Gene 2920] {aka CINC-2a, GRO2, GROb, MGSA-b, MIP-2a, MIP2}, CXCL3 (C-X-C motif chemokine ligand 3) [NCBI Gene 2921] {aka CINC-2b, GRO3, GROg, MIP-2b, MIP2B, SCYB3}, CD68 (CD68 molecule) [NCBI Gene 968] {aka GP110, LAMP4, SCARD1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, MS4A7 (membrane spanning 4-domains A7) [NCBI Gene 58475] {aka 4SPAN2, CD20L4, CFFM4, MS4A8}, PDCD1 (programmed cell death 1) [NCBI Gene 5133] {aka ADMIO4, AIMTBS, CD279, PD-1, PD1, SLEB2}, CX3CL1 (C-X3-C motif chemokine ligand 1) [NCBI Gene 6376] {aka ABCD-3, C3Xkine, CXC3, CXC3C, NTN, NTT}, KIT (KIT proto-oncogene, receptor tyrosine kinase) [NCBI Gene 3815] {aka C-Kit, CD117, MASTC, PBT, SCFR}, MRC1 (mannose receptor C-type 1) [NCBI Gene 4360] {aka CD206, CLEC13D, CLEC13DL, MMR, MRC1L1, bA541I19.1}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, CD40 (CD40 molecule) [NCBI Gene 958] {aka Bp50, CDW40, TNFRSF5, p50}, COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 1277] {aka CAFYD, EDSARTH1, EDSC, OI1, OI2, OI3}, FBXO6 (F-box protein 6) [NCBI Gene 26270] {aka FBG2, FBS2, FBX6, Fbx6b}, VIM (vimentin) [NCBI Gene 7431], ESR2 (estrogen receptor 2) [NCBI Gene 2100] {aka ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2}, EPCAM (epithelial cell adhesion molecule) [NCBI Gene 4072] {aka Ber-Ep4, BerEp4, DIAR5, EGP-2, EGP314, EGP40}, PLG (plasminogen) [NCBI Gene 5340] {aka HAE4}, CD2 (CD2 molecule) [NCBI Gene 914] {aka LFA-2, SRBC, T11}, Star (steroidogenic acute regulatory protein) [NCBI Gene 20845] {aka D8Ertd419e, stARD1}, STAR (steroidogenic acute regulatory protein) [NCBI Gene 6770] {aka STARD1}, CDH5 (cadherin 5) [NCBI Gene 1003] {aka 7B4, CD144}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, COL3A1 (collagen type III alpha 1 chain) [NCBI Gene 1281] {aka EDS4A, EDSVASC, PMGEDSV}, KRT15 (keratin 15) [NCBI Gene 3866] {aka CK15, K15, K1CO}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, CX3CR1 (C-X3-C motif chemokine receptor 1) [NCBI Gene 1524] {aka CCRL1, CMKBRL1, CMKDR1, GPR13, GPRV28, V28}, MYCT1 (MYC target 1) [NCBI Gene 80177] {aka MTLC}, FCGR3A (Fc gamma receptor IIIa) [NCBI Gene 2214] {aka CD16-II, CD16A, FCG3, FCGR3, FCRIIIA, FcGRIIIA}, VCAN (versican) [NCBI Gene 1462] {aka CSPG2, ERVR, GHAP, PG-M, WGN, WGN1}, CYP19A1 (cytochrome P450 family 19 subfamily A member 1) [NCBI Gene 1588] {aka ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX}, TRDC (T cell receptor delta constant) [NCBI Gene 28526] {aka TCRD}, TIGIT (T cell immunoreceptor with Ig and ITIM domains) [NCBI Gene 201633] {aka VSIG9, VSTM3, WUCAM}, IL2RA (interleukin 2 receptor subunit alpha) [NCBI Gene 3559] {aka CD25, IDDM10, IL2R, IMD41, TCGFR, p55}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, CTRL (chymotrypsin like) [NCBI Gene 1506] {aka CTRL1}, CLEC2D (C-type lectin domain family 2 member D) [NCBI Gene 29121] {aka CLAX, LLT1, OCIL}, CD1C (CD1c molecule) [NCBI Gene 911] {aka BDCA1, CD1, R7}, FCGR1A (Fc gamma receptor Ia) [NCBI Gene 2209] {aka CD64, CD64A, FCG1, FCGR1, FCRI, FcgammaRI}, COL1A2 (collagen type I alpha 2 chain) [NCBI Gene 1278] {aka EDSARTH2, EDSCV, OI4}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CCR2 (C-C motif chemokine receptor 2) [NCBI Gene 729230] {aka CC-CKR-2, CCR-2, CCR2A, CCR2B, CD192, CKR2}, AQP1 (aquaporin 1 (Colton blood group)) [NCBI Gene 358] {aka AQP-CHIP, CHIP28, CO}, FGFR4 (fibroblast growth factor receptor 4) [NCBI Gene 2264] {aka CD334, JTK2, TKF}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, NECTIN3 (nectin cell adhesion molecule 3) [NCBI Gene 25945] {aka CD113, CDW113, NECTIN-3, PPR3, PRR3, PVRL3}, KRT19 (keratin 19) [NCBI Gene 3880] {aka CK19, K19, K1CS}, KRT5 (keratin 5) [NCBI Gene 3852] {aka CK5, DDD, DDD1, EBS1, EBS2, EBS2A}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}
- **Diseases:** fibrosis (MESH:D005355), malignant tumours (MESH:D009369), Menstrual cycle Disease (OMIM:614674), immune (MESH:D007154), ectopic diseases (MESH:C566852), ovary endometriosis (MESH:D010051), ectopic endometrium (MESH:D016889), Endometriosis (MESH:D004715), inflammation (MESH:D007249), pain (MESH:D010146), adenomyosis (MESH:D062788), pelvic pain (MESH:D017699), death (MESH:D003643), Dysmenorrhea (MESH:D004412), Infertility (MESH:D007246), Menstruation (MESH:D008599), endometriotic lesions (MESH:D009059), hypoxia (MESH:D000860), gynaecological disease (MESH:D004194), Ovarian endometriosis (MESH:D010049)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** T-8 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_2588), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), M — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_M133), SC-T-8 — Homo sapiens (Human), Floor of mouth squamous cell carcinoma, Cancer cell line (CVCL_L893), -T-5_ — Homo sapiens (Human), Embryonic stem cell (CVCL_C751)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC8261960/full.md

---
Source: https://tomesphere.com/paper/PMC8261960